Chronic Disease Management Strategies
Chronic Disease Management Strategies is a research topic within Epidemiology. Science Explorer counts 34k research works in it since 1950. 21.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, implications, and management of multimorbidity, particularly in older adults. It explores the prevalence, impact on healthcare utilization, quality of life, and the challenges faced in providing care for individuals with multiple chronic conditions in primary care settings. The papers also discuss the development and adaptation of clinical guidelines, as well as the need for patient-centered approaches to address the complex needs associated with multimorbidity.
- Multimorbidity
- Chronic Conditions
- Healthcare Utilization
- Quality of Life
- Primary Care
- Comorbidity
- Epidemiology
- Health Services
- Patient Complexity
- Clinical Practice Guidelines
- Research works
- 34k fractional, since 1950
- In the world top 10%
- 7.1k per year above
- Top-10% rate
- 21.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +51% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Chronic Disease Management Strategies research?
By volume, the United States and China publish the most (1.9k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.9k works
- 2 China 1.1k works
- 3 United Kingdom 1k works
- 4 India 336 works
- 5 Canada 329 works
- 6 Spain 302 works
- 7 Australia 288 works
- 8 Germany 286 works
- 9 Netherlands 221 works
- 10 Japan 198 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Chronic Disease Management Strategies research?
By volume in 2022–2025, Peking University publishes the most Chronic Disease Management Strategies research, followed by University of North Carolina at Chapel Hill and University College London.
By volume, 2022–2025
- 1 Peking UniversityChina 42 works
- 2 University of North Carolina at Chapel HillUnited States 39 works
- 3 University College LondonUnited Kingdom 35 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 32 works
- 5 Harvard UniversityUnited States 31 works
- 6 Johns Hopkins UniversityUnited States 29 works
- 7 King's College LondonUnited Kingdom 28 works
- 8 Imperial College LondonUnited Kingdom 26 works
- 9 University of OxfordUnited Kingdom 26 works
- 10 Karolinska InstitutetSweden 25 works
Who are the leading researchers in Chronic Disease Management Strategies?
The most-cited researchers publishing on Chronic Disease Management Strategies include Christopher J L Murray, Theo Vos and Ali H. Mokdad.
- 1 Christopher J L Murray United States 13k citations
- 2 Theo Vos United States 12k citations
- 3 Ali H. Mokdad United States 10k citations
- 4 Yousef Khader Jordan 7.7k citations
- 5 Nelson Alvis‐Guzmán Colombia 7.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Chronic Disease Management Strategies research done?
The largest centres of Chronic Disease Management Strategies research in 2022–2025 are London (United Kingdom), Beijing (China), New York (United States) and Singapore (Singapore). Among places with at least 20 works in it, it is an unusually large share of all research in Leicester and Odense.
Largest cities, 2022–2025
Where it is the local speciality
- LeicesterGB · 31.1 works7.5×
- OdenseDK · 24.5 works6.6×
Location quotient: how much more of its research is in Chronic Disease Management Strategies than the world average.
Where is the best place to study Chronic Disease Management Strategies?
Among universities, judged by research, International Institute for Population Sciences, London School of Hygiene & Tropical Medicine and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | International Institute for Population SciencesIndia | 70.4 | 52.9% | 54.2× | 16 | — |
| 2 | London School of Hygiene & Tropical MedicineUnited Kingdom | 66.0 | 31.8% | 10.4× | 14 | +85.1% |
| 3 | Karolinska InstitutetSweden | 57.7 | 29.6% | 6.4× | 25 | +59.0% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.3 | 31.9% | 3.8× | 32 | +158.6% |
| 5 | Peking UniversityChina | 54.8 | 35.0% | 3.1× | 42 | +80.9% |
| 6 | King's College LondonUnited Kingdom | 53.8 | 26.4% | 4.3× | 28 | +138.5% |
| 7 | Sichuan UniversityChina | 53.2 | 46.5% | 1.2× | 18 | +338.9% |
| 8 | University of Southern DenmarkDenmark | 53.1 | 28.3% | 6.3× | 18 | +92.8% |
| 9 | Harvard UniversityUnited States | 51.8 | 34.3% | 2.8× | 31 | +74.2% |
| 10 | King Saud UniversitySaudi Arabia | 49.2 | 36.5% | 1.7× | 13 | +172.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Chronic Disease Management Strategies research growing?
Output in 2018–2022 was 51% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chronic Disease Management Strategies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.